Clinical Trial Update: LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors [NA]

View source ↗

Summary

A terminated clinical trial evaluating LC Bead LUMI radiopaque embolic beads for detecting and characterizing hepatic tumor vascularity has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Drugs mentioned

• LC Bead LUMI

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Hepatic Cancer, Liver Neoplasms | NA | Status: TERMINATED | Results posted: 2024-07-11